Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. (original) (raw)
Research Article Free access | 10.1172/JCI116129
J L Wang, M A Sweetland, J R Lancaster Jr, and M L McDaniel
Department of Pathology, Washington University School of Medicine, Saint Louis 63110.
Find articles by Corbett, J. in:PubMed |Google Scholar
Department of Pathology, Washington University School of Medicine, Saint Louis 63110.
Find articles by Wang, J. in:PubMed |Google Scholar
Department of Pathology, Washington University School of Medicine, Saint Louis 63110.
Find articles by Sweetland, M. in:PubMed |Google Scholar
Department of Pathology, Washington University School of Medicine, Saint Louis 63110.
Find articles by Lancaster, J. in:PubMed |Google Scholar
Department of Pathology, Washington University School of Medicine, Saint Louis 63110.
Find articles by McDaniel, M. in:PubMed |Google Scholar
Published December 1, 1992 -More info
Published December 1, 1992 -Version history
Nitric oxide has recently been implicated as the effector molecule that mediates IL-1 beta-induced inhibition of glucose-stimulated insulin secretion and beta-cell specific destruction. The pancreatic islet represents a heterogeneous cell population containing both endocrine cells (beta-[insulin], alpha-]glucagon], gamma[somatostatin], and PP-[polypeptide] secreting cells) and non-endocrine cells (fibroblast, macrophage, endothelial, and dendritic cells). The purpose of this investigation was to determine if the beta-cell, which is selectively destroyed during insulin-dependent diabetes mellitus, is both a source of IL-1 beta-induced nitric oxide production and also a site of action of this free radical. Pretreatment of beta-cells, purified by FACS with IL-1 beta results in a 40% inhibition of glucose-stimulated insulin secretion that is prevented by the nitric oxide synthase inhibitor, NG-monomethyl-L-arginine (NMMA). IL-1 beta induces the formation of nitric oxide by purified beta-cells as evidenced by the accumulation of cGMP, which is blocked by NMMA. IL-1 beta also induces the accumulation of cGMP by the insulinoma cell line Rin-m5F, and both NMMA as well as the protein synthesis inhibitor cycloheximide prevent this cGMP accumulation. Iron-sulfur proteins appear to be intracellular targets of nitric oxide. IL-1 beta induces the formation of an iron-dinitrosyl complex by Rin-m5F cells indicating that nitric oxide mediates the destruction of iron-sulfur clusters of iron containing enzymes. This is further demonstrated by IL-1 beta-induced inhibition of glucose oxidation by purified beta-cells, mitochondrial aconitase activity of dispersed islet cells, and mitochondrial aconitase activity of Rin-m5F cells, all of which are prevented by NMMA. IL-1 beta does not appear to affect FACS-purified alpha-cell metabolic activity or intracellular cGMP levels, suggesting that IL-1 beta does not exert any effect on alpha-cells. These results demonstrate that the islet beta-cell is a source of IL-1 beta-induced nitric oxide production, and that beta-cell mitochondrial iron-sulfur containing enzymes are one site of action of nitric oxide.
Click on an image below to see the page. View PDF of the complete article
- Version 1 (December 1, 1992): No description